The drug substance patent on Dasatinib was owned by
Bristol-Myers-Squibb and had expired on 12 April 12, 2020. The current
monthly therapy cost of innovator is approximately Rs 1.65 lakh,
Shilpa Medicare said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/shilpa-medicare-launches-cancer-drug-at-monthly-therapy-cost-of-rs-6440/articleshow/75342045.cms
Thursday, April 23, 2020
FREE Webinar: Top 5 Job Skills and Courses in Demand After COVID-19 Pandemic
COVID-19 Courses & Skills in Demand – Free Webinar UPCOMING WEBINAR
ALERT Top 5 Job Skills and Courses in Demand After COVID-19 Pandemic
The year 2020 started with one of the most challenging health
emergencies the world has ever faced in the past 100 years! In the
past 3 months, the novel Coronavirus COVID 19 […]
The post FREE Webinar: Top 5 Job Skills and Courses in Demand After
COVID-19 Pandemic appeared first on BioTecNika .
https://www.biotecnika.org/2020/04/free-webinar-top-5-job-skills-and-courses-in-demand-after-covid-19-pandemic/
BioTecNika TV,Career Advice,Featured
ALERT Top 5 Job Skills and Courses in Demand After COVID-19 Pandemic
The year 2020 started with one of the most challenging health
emergencies the world has ever faced in the past 100 years! In the
past 3 months, the novel Coronavirus COVID 19 […]
The post FREE Webinar: Top 5 Job Skills and Courses in Demand After
COVID-19 Pandemic appeared first on BioTecNika .
https://www.biotecnika.org/2020/04/free-webinar-top-5-job-skills-and-courses-in-demand-after-covid-19-pandemic/
BioTecNika TV,Career Advice,Featured
AIIMS Life Science Research Fellow Recruitment – Apply Online
AIIMS Life Science Research Fellow Recruitment – Apply Online AIIMS
Life Science Research Fellow Recruitment – Apply Online. AIIMS Bhopal
Life Science, Junior Research Fellow Post. AIIMS Bhopal recruiting MSc
candidates with relevant experience for research positions. Check out
all of the below: This job expires in : Detailed Advertisement:
Advt.No: AIIMS/Bhopal/SERB/CRG/Myco-2020/01/UR Position Name: […]
The post AIIMS Life Science Research Fellow Recruitment – Apply Online
appeared first on BioTecNika .
https://www.biotecnika.org/2020/04/aiims-life-science-research-fellow-recruitment-apply-online/
Jobs,Life Sciences Jobs,M.Sc
Life Science Research Fellow Recruitment – Apply Online. AIIMS Bhopal
Life Science, Junior Research Fellow Post. AIIMS Bhopal recruiting MSc
candidates with relevant experience for research positions. Check out
all of the below: This job expires in : Detailed Advertisement:
Advt.No: AIIMS/Bhopal/SERB/CRG/Myco-2020/01/UR Position Name: […]
The post AIIMS Life Science Research Fellow Recruitment – Apply Online
appeared first on BioTecNika .
https://www.biotecnika.org/2020/04/aiims-life-science-research-fellow-recruitment-apply-online/
Jobs,Life Sciences Jobs,M.Sc
Biotecnika Times – Newsletter 24.04.2020 – Govt Ministry of Health Job, ICMR COVID Funding
Biotecnika Times – Govt Ministry of Health Job, ICMR COVID Funding
Govt Ministry of Health Biotech / Life Science Research Recruitment –
Salary of Rs. 48,000 pm Govt Ministry of Health Biotech / Life Science
Research Recruitment – Salary of Rs. 48,000 pm. BE/BTech Biotech /
MSc/ PhD Life Science candidates can apply. CSIR Corona […]
The post Biotecnika Times – Newsletter 24.04.2020 – Govt Ministry of
Health Job, ICMR COVID Funding appeared first on BioTecNika .
https://www.biotecnika.org/2020/04/biotecnika-times-newsletter-24-04-2020-govt-ministry-of-health-job-icmr-covid-funding/
BioTecNika Times
Govt Ministry of Health Biotech / Life Science Research Recruitment –
Salary of Rs. 48,000 pm Govt Ministry of Health Biotech / Life Science
Research Recruitment – Salary of Rs. 48,000 pm. BE/BTech Biotech /
MSc/ PhD Life Science candidates can apply. CSIR Corona […]
The post Biotecnika Times – Newsletter 24.04.2020 – Govt Ministry of
Health Job, ICMR COVID Funding appeared first on BioTecNika .
https://www.biotecnika.org/2020/04/biotecnika-times-newsletter-24-04-2020-govt-ministry-of-health-job-icmr-covid-funding/
BioTecNika Times
Some drugs more essential, govt moves to ensure supply
The government has identified 55 drugs that hospitals in India need to
manage coronavirus patients in intensive care units.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/some-drugs-more-essential-govt-moves-to-ensure-supply/articleshow/75339240.cms
manage coronavirus patients in intensive care units.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/some-drugs-more-essential-govt-moves-to-ensure-supply/articleshow/75339240.cms
Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation and Harvard's Faculty of Arts and Sciences
LabXchange by Amgen Foundation and Harvard's Faculty of Arts and
Sciences Reimagines the Science Experience for Students around the
Globe
Purpose-built to Address Educational Barriers with Personalized Instruction
Virtual Lab Simulations Help Students Develop the Science Skills
Needed to Solve Tomorrow's Challenges
THOUSAND OAKS, Calif. and CAMBRIDGE, Mass. – The Amgen Foundation and
the Faculty of Arts and Sciences at Harvard University (Harvard FAS)
today announced the global launch of LabXchange™, a free online
science education platform that provides users with access to
personalized instruction, virtual lab experiences and networking
opportunities across the global scientific community. LabXchange is
purpose-built to drive more inclusion in the scientific process and
spark collaboration to build creative, team-based approaches to
real-world problems.
"Too many high school and college students lack the opportunity to
directly explore the scientific process – where you build a
hypothesis, understand a method, and determine how to apply it to an
appropriate experimental problem," said Robert Lue, Ph.D., principal
investigator of LabXchange and professor of the Practice of Molecular
and Cellular Biology at Harvard. "For many students, science can feel
like a collection of facts to memorize – which is contrary to what the
scientific process is – it's a journey that requires bold thinking and
deep imagination. With LabXchange, more students can come together and
experience the joy of discovery."
Featuring virtual lab experiments developed at LabXchange along with
other world-class assets created by validated partners, LabXchange
brings the scientific process to life. By simulating key techniques in
molecular and cellular biology, like using CRISPR to correct genetic
defects, students can explore a wide range of scientific methods and
build their acumen in harnessing science to solve real-life problems.
"Everyone needs science, and science needs everyone," said Robert A.
Bradway, chairman and chief executive officer at Amgen. "At a time of
remarkable scientific progress, we're excited by the potential of
LabXchange to educate and inspire both students and lifelong learners
of all ages."
LabXchange is designed to level the playing field for students and to
promote science literacy for all. Key features of LabXchange include:
Free access to a library of world-class educational content including
videos, interactive simulation and assessments.
Ability to mix and match materials, empowering teachers to create
flexible learning pathways for classes or individual students that
complement existing science curriculums.
Global networking functionality, enabling teachers to collaborate
beyond a single classroom, school or district.
LabXchange builds upon other Amgen Foundation programs that support
science education, such as the Amgen Biotech Experience and Amgen
Scholars that are also at Harvard FAS and institutions around the
world. To date, the Foundation has contributed more than $150 million
to advancing science education programming globally as part of its
mission to facilitate global collaboration on the United Nations
Sustainable Development Goals (SDGs), notably SDG #4 on Quality
Education but also SDG #3 on Good Health and Well-Being.
For more information, please visit www.LabXchange.org , and engage
with us via @LabXchange on Twitter using #ScienceMadePossible.
About the Amgen Foundation
The Amgen Foundation seeks to advance excellence in science education
to inspire the next generation of innovators, and invest in
strengthening communities where Amgen staff members live and work. To
date, the Foundation has donated over $300 million to local, regional,
and international nonprofit organizations that impact society in
inspiring and innovative ways. The Amgen Foundation brings the
excitement of discovery to the scientists of tomorrow through several
signature programs, including Amgen Scholars and the Amgen Biotech
Experience. For more information, visit AmgenInspires.com and follow
us on Twitter @AmgenFoundation .
About Amgen
Amgen is committed to unlocking the potential of biology for patients
suffering from serious illnesses by discovering, developing,
manufacturing and delivering innovative human therapeutics. This
approach begins by using tools like advanced human genetics to unravel
the complexities of disease and understand the fundamentals of human
biology.
Amgen focuses on areas of high unmet medical need and leverages its
expertise to strive for solutions that improve health outcomes and
dramatically improve people's lives. A biotechnology pioneer since
1980, Amgen has grown to be one of the world's leading independent
biotechnology companies, has reached millions of patients around the
world and is developing a pipeline of medicines with breakaway
potential.
For more information, visit www.amgen.com and follow us on Twitter @Amgen .
About the Faculty of Arts and Sciences at Harvard University
The Faculty of Arts and Sciences is the largest of the seven faculties
that constitute Harvard University and is the only division of the
university responsible for both undergraduate and graduate education.
FAS advances knowledge, improves learning, and shapes leaders.
For more information, visit www.fas.harvard.edu/
https://www.harvard.edu/media-relations/free-labxchange-science-education-accelerator-launched-by-amgen-foundation-and
Sciences Reimagines the Science Experience for Students around the
Globe
Purpose-built to Address Educational Barriers with Personalized Instruction
Virtual Lab Simulations Help Students Develop the Science Skills
Needed to Solve Tomorrow's Challenges
THOUSAND OAKS, Calif. and CAMBRIDGE, Mass. – The Amgen Foundation and
the Faculty of Arts and Sciences at Harvard University (Harvard FAS)
today announced the global launch of LabXchange™, a free online
science education platform that provides users with access to
personalized instruction, virtual lab experiences and networking
opportunities across the global scientific community. LabXchange is
purpose-built to drive more inclusion in the scientific process and
spark collaboration to build creative, team-based approaches to
real-world problems.
"Too many high school and college students lack the opportunity to
directly explore the scientific process – where you build a
hypothesis, understand a method, and determine how to apply it to an
appropriate experimental problem," said Robert Lue, Ph.D., principal
investigator of LabXchange and professor of the Practice of Molecular
and Cellular Biology at Harvard. "For many students, science can feel
like a collection of facts to memorize – which is contrary to what the
scientific process is – it's a journey that requires bold thinking and
deep imagination. With LabXchange, more students can come together and
experience the joy of discovery."
Featuring virtual lab experiments developed at LabXchange along with
other world-class assets created by validated partners, LabXchange
brings the scientific process to life. By simulating key techniques in
molecular and cellular biology, like using CRISPR to correct genetic
defects, students can explore a wide range of scientific methods and
build their acumen in harnessing science to solve real-life problems.
"Everyone needs science, and science needs everyone," said Robert A.
Bradway, chairman and chief executive officer at Amgen. "At a time of
remarkable scientific progress, we're excited by the potential of
LabXchange to educate and inspire both students and lifelong learners
of all ages."
LabXchange is designed to level the playing field for students and to
promote science literacy for all. Key features of LabXchange include:
Free access to a library of world-class educational content including
videos, interactive simulation and assessments.
Ability to mix and match materials, empowering teachers to create
flexible learning pathways for classes or individual students that
complement existing science curriculums.
Global networking functionality, enabling teachers to collaborate
beyond a single classroom, school or district.
LabXchange builds upon other Amgen Foundation programs that support
science education, such as the Amgen Biotech Experience and Amgen
Scholars that are also at Harvard FAS and institutions around the
world. To date, the Foundation has contributed more than $150 million
to advancing science education programming globally as part of its
mission to facilitate global collaboration on the United Nations
Sustainable Development Goals (SDGs), notably SDG #4 on Quality
Education but also SDG #3 on Good Health and Well-Being.
For more information, please visit www.LabXchange.org , and engage
with us via @LabXchange on Twitter using #ScienceMadePossible.
About the Amgen Foundation
The Amgen Foundation seeks to advance excellence in science education
to inspire the next generation of innovators, and invest in
strengthening communities where Amgen staff members live and work. To
date, the Foundation has donated over $300 million to local, regional,
and international nonprofit organizations that impact society in
inspiring and innovative ways. The Amgen Foundation brings the
excitement of discovery to the scientists of tomorrow through several
signature programs, including Amgen Scholars and the Amgen Biotech
Experience. For more information, visit AmgenInspires.com and follow
us on Twitter @AmgenFoundation .
About Amgen
Amgen is committed to unlocking the potential of biology for patients
suffering from serious illnesses by discovering, developing,
manufacturing and delivering innovative human therapeutics. This
approach begins by using tools like advanced human genetics to unravel
the complexities of disease and understand the fundamentals of human
biology.
Amgen focuses on areas of high unmet medical need and leverages its
expertise to strive for solutions that improve health outcomes and
dramatically improve people's lives. A biotechnology pioneer since
1980, Amgen has grown to be one of the world's leading independent
biotechnology companies, has reached millions of patients around the
world and is developing a pipeline of medicines with breakaway
potential.
For more information, visit www.amgen.com and follow us on Twitter @Amgen .
About the Faculty of Arts and Sciences at Harvard University
The Faculty of Arts and Sciences is the largest of the seven faculties
that constitute Harvard University and is the only division of the
university responsible for both undergraduate and graduate education.
FAS advances knowledge, improves learning, and shapes leaders.
For more information, visit www.fas.harvard.edu/
https://www.harvard.edu/media-relations/free-labxchange-science-education-accelerator-launched-by-amgen-foundation-and
Harvard Statement on Decision to Not Accept Funds from the CARES Act Higher Education Emergency Relief Fund
April 22, 2020
There has been confusion in recent days about funds allocated to
Harvard as part of the CARES Act.
Like most colleges and universities, Harvard has been allocated funds
as part of the CARES Act Higher Education Emergency Relief Fund.
Harvard did not apply for this support, nor has it requested, received
or accessed these funds.
We have previously said that Harvard, like other institutions, will
face significant financial challenges due to the pandemic and economic
crisis it has caused. We are also concerned however, that the intense
focus by politicians and others on Harvard in connection with this
program may undermine participation in a relief effort that Congress
created and the President signed into law for the purpose of helping
students and institutions whose financial challenges in the coming
months may be most severe. As a result of this, and the evolving
guidance being issued around use of the Higher Education Emergency
Relief Fund, Harvard has decided not to seek or accept the funds
allocated to it by statute.
We will inform the Department of Education of our decision and
encourage the department to act swiftly to reallocate resources
previously allocated to Harvard. While we understand any reallocation
of these resources is a matter for the Department of Education, we
hope that special consideration will be given to Massachusetts
institutions that are struggling to serve their communities and meet
the needs of their students through these difficult and challenging
times.
Harvard remains fully committed to providing the financial support
that it has promised to its students.
https://www.harvard.edu/media-relations/cares-act
There has been confusion in recent days about funds allocated to
Harvard as part of the CARES Act.
Like most colleges and universities, Harvard has been allocated funds
as part of the CARES Act Higher Education Emergency Relief Fund.
Harvard did not apply for this support, nor has it requested, received
or accessed these funds.
We have previously said that Harvard, like other institutions, will
face significant financial challenges due to the pandemic and economic
crisis it has caused. We are also concerned however, that the intense
focus by politicians and others on Harvard in connection with this
program may undermine participation in a relief effort that Congress
created and the President signed into law for the purpose of helping
students and institutions whose financial challenges in the coming
months may be most severe. As a result of this, and the evolving
guidance being issued around use of the Higher Education Emergency
Relief Fund, Harvard has decided not to seek or accept the funds
allocated to it by statute.
We will inform the Department of Education of our decision and
encourage the department to act swiftly to reallocate resources
previously allocated to Harvard. While we understand any reallocation
of these resources is a matter for the Department of Education, we
hope that special consideration will be given to Massachusetts
institutions that are struggling to serve their communities and meet
the needs of their students through these difficult and challenging
times.
Harvard remains fully committed to providing the financial support
that it has promised to its students.
https://www.harvard.edu/media-relations/cares-act
Subscribe to:
Posts (Atom)